49.86
전일 마감가:
$52.01
열려 있는:
$51.94
하루 거래량:
2.53M
Relative Volume:
1.18
시가총액:
$17.83B
수익:
$2.26B
순이익/손실:
$117.50M
주가수익비율:
166.20
EPS:
0.3
순현금흐름:
$-220.60M
1주 성능:
-3.69%
1개월 성능:
-11.61%
6개월 성능:
+24.15%
1년 성능:
+11.79%
칼라일 그룹 Stock (CG) Company Profile
명칭
Carlyle Group Inc
전화
202 729 5626
주소
C/O THE CARLYLE GROUP, WASHINGTON, DC
CG을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CG
Carlyle Group Inc
|
49.86 | 17.83B | 2.26B | 117.50M | -220.60M | 0.30 |
![]()
BLK
Blackrock Inc
|
974.22 | 150.89B | 20.41B | 6.37B | 4.05B | 42.00 |
![]()
BX
Blackstone Inc
|
158.38 | 121.75B | 10.93B | 2.78B | 4.14B | 3.63 |
![]()
KKR
Kkr Co Inc
|
132.22 | 117.44B | 21.64B | 3.08B | 7.75B | 3.28 |
![]()
BAM
Brookfield Asset Management Ltd
|
58.57 | 94.53B | 0 | 1.04B | 0 | 1.27 |
![]()
BN
Brookfield Corporation
|
58.86 | 88.79B | 86.01B | 641.00M | -4.81B | 0.3007 |
칼라일 그룹 Stock (CG) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-01-03 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
2024-09-12 | 개시 | Wells Fargo | Equal Weight |
2024-08-27 | 개시 | Redburn Atlantic | Buy |
2024-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2024-01-19 | 다운그레이드 | Citigroup | Buy → Neutral |
2024-01-04 | 개시 | TD Cowen | Market Perform |
2023-11-29 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2023-10-05 | 개시 | Wolfe Research | Peer Perform |
2023-05-19 | 개시 | Citigroup | Buy |
2023-03-02 | 개시 | Barclays | Overweight |
2023-01-03 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
2022-10-19 | 개시 | Credit Suisse | Outperform |
2022-09-06 | 다운그레이드 | BofA Securities | Buy → Underperform |
2022-08-09 | 다운그레이드 | Jefferies | Buy → Hold |
2022-07-29 | 업그레이드 | Evercore ISI | In-line → Outperform |
2022-06-08 | 개시 | JMP Securities | Mkt Outperform |
2021-12-16 | 개시 | BofA Securities | Buy |
2021-09-13 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
2021-08-11 | 업그레이드 | Deutsche Bank | Hold → Buy |
2021-02-19 | 업그레이드 | Credit Suisse | Neutral → Outperform |
2021-01-19 | 업그레이드 | Keefe Bruyette | Mkt Perform → Outperform |
2020-11-20 | 업그레이드 | BofA Securities | Underperform → Buy |
2020-10-12 | 업그레이드 | Citigroup | Neutral → Buy |
2020-06-08 | 다운그레이드 | Citigroup | Buy → Neutral |
2020-04-15 | 업그레이드 | Citigroup | Neutral → Buy |
2020-03-23 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
2020-02-06 | 다운그레이드 | Citigroup | Buy → Neutral |
2020-02-06 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
2019-12-12 | 다운그레이드 | UBS | Buy → Neutral |
2019-10-08 | 개시 | BMO Capital Markets | Market Perform |
2019-09-23 | 재확인 | BofA/Merrill | Neutral |
2019-08-05 | 개시 | Barclays | Equal Weight |
2019-05-21 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
2019-03-29 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
2019-01-04 | 업그레이드 | Goldman | Neutral → Buy |
2018-11-14 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2018-03-12 | 업그레이드 | Citigroup | Neutral → Buy |
2018-02-14 | 업그레이드 | Jefferies | Hold → Buy |
2017-10-10 | 다운그레이드 | Citigroup | Buy → Neutral |
2017-06-08 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2017-05-11 | 업그레이드 | Credit Suisse | Neutral → Outperform |
모두보기
칼라일 그룹 주식(CG)의 최신 뉴스
Bluebird Bio to Be Acquired by Carlyle Group, SK Capital - The Wall Street Journal
Bluebird bio Agrees to be Acquired by Carlyle Group, SK Capital Partners; Shares Fall Sharply - Marketscreener.com
Gene therapy maker bluebird to go private in discounted deal amid cash crunch - Reuters
Carlyle Group Explores Asset-Based Finance as Key Growth SectorNews and Statistics - IndexBox, Inc.
Sector Update: Financial Stocks Advance Pre-Bell Friday -February 21, 2025 at 09:27 am EST - Marketscreener.com
Bluebird Bio Announces Definitive Agreement To Be Acquired By Carlyle And SK Capital - Marketscreener.com
Carlyle price target lowered to $47 from $50 at BofA - Yahoo Finance
What's Going On With Gene Therapy Company Bluebird Bio Stock Today? - Benzinga
What's Driving the Market Sentiment Around Carlyle Group? - Benzinga
bluebird bio announces take-private deal with Carlyle and SK Capital - MSN
Bluebird Bio To Be Taken Private By Carlyle And SK Capital Partners - Nasdaq
Carlyle and SK Capital to acquire bluebird bio By Investing.com - Investing.com UK
Bluebird bio to be taken private by Carlyle and SK Capital amid cash crunch -February 21, 2025 at 08:14 am EST - Marketscreener.com
Bluebird bio Agrees to be Acquired by Carlyle Group, SK Capital Partners; Trading Halted Pre-Bell - Marketscreener.com
Bluebird bio agrees to be acquired by Carlyle and SK Capital -February 21, 2025 at 07:36 am EST - Marketscreener.com
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital - Business Wire
Carlyle Group Among Final Bidders for HgCapital's smartTrade Technologies -February 21, 2025 at 06:05 am EST - Marketscreener.com
Carlyle and SK Capital to take gene therapy firm bluebird bio private - PE Hub
Carlyle COO Touts Asset-Based Finance as Next Frontier - Bloomberg
Carlyle group general counsel Jeffrey Ferguson sells $13.3 million in shares - Investing.com
Carlyle Group General Counsel Sells 250,000 Shares - TradingView
Carlyle and Thoma Bravo Among Final Bidders for SmartTrade TechnologiesNews and Statistics - IndexBox, Inc.
Carlyle, Thoma Bravo Shortlisted in Bidding for SmartTrade - Yahoo Finance
The Search For 7% Investment Grade Yields, Part 2: Carlyle And Its Baby Bond - Seeking Alpha
Carlyle's India Head on Hexaware Technologies IPO -February 20, 2025 at 05:48 am EST - Marketscreener.com
Carlyle remains committed to Hexaware, as it gets listed - Communications Today
Ex-Dividend Reminder: Primerica, Carlyle Group and Abrdn Healthcare Opportunities Fund - Nasdaq
Goldman Sachs Partner Alibair Exits to Join Carlyle in New Role - Bloomberg
Carlyle-backed IT exporter Hexaware valued at $5 bn on market debut day - Business Standard
Carlyle Group’s Hexaware to Debut After India’s First Billion-Dollar IPO of Year - Bloomberg
Carlyle Group's Hexaware to Debut After India's First Billion-Dollar IPO of Year - Financial Post
Carlyle Group's SWOT analysis: stock outlook amid mixed Q4 results - MSN
Carlyle Group's SWOT analysis: stock outlook amid mixed Q4 results By Investing.com - Investing.com Nigeria
The Carlyle Group Inc. (NASDAQ:CG) Stake Lessened by Empowered Funds LLC - MarketBeat
The Carlyle Group (NASDAQ:CG) Posts Earnings Results, Misses Expectations By $0.08 EPS - MarketBeat
The Carlyle Group Inc. (NASDAQ:CG) Is About To Go Ex-Dividend, And It Pays A 2.7% Yield - Yahoo Finance UK
Sumitomo Mitsui Trust Group Inc. Acquires 7,891 Shares of The Carlyle Group Inc. (NASDAQ:CG) - MarketBeat
The Carlyle Group (NASDAQ:CG) Upgraded by StockNews.com to "Hold" Rating - MarketBeat
The Carlyle Group (NASDAQ:CG) Given New $55.00 Price Target at Barclays - MarketBeat
The Carlyle Group Inc. (NASDAQ:CG) Declares $0.35 Quarterly Dividend - MarketBeat
Stanley Laman Group Ltd. Cuts Stock Holdings in The Carlyle Group Inc. (NASDAQ:CG) - MarketBeat
Polaris Capital Management LLC Has $37.62 Million Stake in The Carlyle Group Inc. (NASDAQ:CG) - MarketBeat
Sumitomo Mitsui DS Asset Management Company Ltd Buys 7,539 Shares of The Carlyle Group Inc. (NASDAQ:CG) - MarketBeat
Carlyle acquires majority stake in Highway-Roop platform - Yahoo
Wells Fargo & Company Issues Pessimistic Forecast for The Carlyle Group (NASDAQ:CG) Stock Price - MarketBeat
Evercore ISI holds Carlyle Group stock with $51 target - MSN
Citi maintains Neutral on Carlyle Group with $55 target - MSN
The Carlyle Group (NASDAQ:CG) Trading Down 4.9% on Disappointing Earnings - MarketBeat
Mirae Asset Global Investments Co. Ltd. Has $1.43 Million Position in The Carlyle Group Inc. (NASDAQ:CG) - MarketBeat
The Carlyle Group Inc. (NASDAQ:CG) Shares Sold by abrdn plc - MarketBeat
The Carlyle Group Target of Unusually Large Options Trading (NASDAQ:CG) - MarketBeat
칼라일 그룹 (CG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
칼라일 그룹 주식 (CG) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Ferguson Jeffrey W. | General Counsel |
Feb 18 '25 |
Sale |
53.20 |
102,342 |
5,444,594 |
1,242,781 |
자본화:
|
볼륨(24시간):